CA1019727A
(en)
|
1971-03-18 |
1977-10-25 |
Abbott Laboratories |
Adenosine-5'-carboxylic acid amides
|
US4029884A
(en)
*
|
1971-03-18 |
1977-06-14 |
Abbott Laboratories |
Adenosine-5'-carboxylic acid amides
|
US3927216A
(en)
|
1971-06-01 |
1975-12-16 |
Icn Pharmaceuticals |
1,2,4-Triazol E-3-carboxamides for inhibiting virus infections
|
US3864483A
(en)
*
|
1972-03-22 |
1975-02-04 |
Abbott Lab |
Adenosine-5{40 -carboxylic acid amides
|
US4351337A
(en)
*
|
1973-05-17 |
1982-09-28 |
Arthur D. Little, Inc. |
Biodegradable, implantable drug delivery device, and process for preparing and using the same
|
US4450150A
(en)
*
|
1973-05-17 |
1984-05-22 |
Arthur D. Little, Inc. |
Biodegradable, implantable drug delivery depots, and method for preparing and using the same
|
US3914415A
(en)
|
1973-06-14 |
1975-10-21 |
Abbott Lab |
Adenosine-5{40 -carboxylic acid amides
|
US3914414A
(en)
|
1973-06-14 |
1975-10-21 |
Abbott Lab |
Method of increasing coronary pO{HD 2 {B in mammals
|
US3892769A
(en)
*
|
1973-07-20 |
1975-07-01 |
Merck & Co Inc |
Acetaminophen esters of aryl salicylic acids
|
US3980766A
(en)
*
|
1973-08-13 |
1976-09-14 |
West Laboratories, Inc. |
Orally administered drug composition for therapy in the treatment of narcotic drug addiction
|
US3966917A
(en)
*
|
1974-07-30 |
1976-06-29 |
Abbott Laboratories |
Platelet aggregation inhibitors
|
DE2530563C2
(de)
*
|
1975-07-09 |
1986-07-24 |
Bayer Ag, 5090 Leverkusen |
Analgetische Arzneimittel mit vermindertem Mißbrauchspotential
|
FR2313915A1
(fr)
|
1976-01-26 |
1977-01-07 |
Corneille Gilbert |
Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme
|
NO154918C
(no)
*
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
|
SE7804231L
(sv)
|
1978-04-14 |
1979-10-15 |
Haessle Ab |
Magsyrasekretionsmedel
|
US4308251A
(en)
|
1980-01-11 |
1981-12-29 |
Boots Pharmaceuticals, Inc. |
Controlled release formulations of orally-active medicaments
|
JPS6056122B2
(ja)
*
|
1980-05-21 |
1985-12-09 |
塩野義製薬株式会社 |
徐放性製剤
|
US4321253A
(en)
*
|
1980-08-22 |
1982-03-23 |
Beatty Morgan L |
Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
|
US4454309A
(en)
*
|
1980-11-12 |
1984-06-12 |
Tyndale Plains-Hunter, Ltd. |
Polyurethane polyene compositions
|
JPS57197214A
(en)
|
1981-05-29 |
1982-12-03 |
Tanabe Seiyaku Co Ltd |
Rapid-releasing microcapsule and its preparation
|
US4443549A
(en)
*
|
1981-10-19 |
1984-04-17 |
Molecular Genetics, Inc. |
Production of monoclonal antibodies against bacterial adhesins
|
US4434153A
(en)
|
1982-03-22 |
1984-02-28 |
Alza Corporation |
Drug delivery system comprising a reservoir containing a plurality of tiny pills
|
US4507276A
(en)
|
1982-08-20 |
1985-03-26 |
Bristol-Myers Company |
Analgesic capsule
|
US4461759A
(en)
*
|
1983-01-03 |
1984-07-24 |
Verex Laboratories, Inc. |
Constant release rate solid oral dosage formulations of veropamil
|
HU187215B
(en)
*
|
1983-01-26 |
1985-11-28 |
Egyt Gyogyszervegyeszeti Gyar |
Method for producing pharmaceutical product of high actor content and prolonged effect
|
US4833905A
(en)
*
|
1983-06-03 |
1989-05-30 |
Micromatic Textron Inc. |
Method for splining clutch hubs with close tolerance spline bellmouth and oil seal surface roundness
|
JPS6051189A
(ja)
*
|
1983-08-30 |
1985-03-22 |
Sankyo Co Ltd |
チアゾリジン誘導体およびその製造法
|
US4894240A
(en)
*
|
1983-12-22 |
1990-01-16 |
Elan Corporation Plc |
Controlled absorption diltiazem formulation for once-daily administration
|
IL75400A
(en)
|
1984-06-16 |
1988-10-31 |
Byk Gulden Lomberg Chem Fab |
Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
|
JPS6150978A
(ja)
|
1984-08-16 |
1986-03-13 |
Takeda Chem Ind Ltd |
ピリジン誘導体およびその製造法
|
AU4640985A
(en)
|
1984-08-31 |
1986-03-06 |
Nippon Chemiphar Co. Ltd. |
Benzimidazole derivatives
|
EP0179023B1
(fr)
|
1984-10-19 |
1991-01-23 |
Battelle Memorial Institute |
Polypeptide biodégradable et son utilisation pour le relargage progressif de médicaments
|
IE58110B1
(en)
*
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
EP0198769A3
(en)
|
1985-04-12 |
1987-09-02 |
Forest Laboratories, Inc. |
Floating sustained release therapeutic compositions
|
US4728512A
(en)
*
|
1985-05-06 |
1988-03-01 |
American Home Products Corporation |
Formulations providing three distinct releases
|
LU85943A1
(fr)
|
1985-06-12 |
1987-01-13 |
Galephar |
Comprimes pharmaceutiques permettant l'administration aisee de pellets, leur preparation et leur utilisation
|
US5002551A
(en)
|
1985-08-22 |
1991-03-26 |
Johnson & Johnson Medical, Inc. |
Method and material for prevention of surgical adhesions
|
US4693896A
(en)
*
|
1985-10-07 |
1987-09-15 |
Fmc Corporation |
Ethylcellulose-coated, gastric-disintegrable aspirin tablet
|
DE3543999A1
(de)
*
|
1985-12-13 |
1987-06-19 |
Bayer Ag |
Hochreine acarbose
|
CA1327010C
(en)
*
|
1986-02-13 |
1994-02-15 |
Tadashi Makino |
Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
|
AU591248B2
(en)
|
1986-03-27 |
1989-11-30 |
Kinaform Technology, Inc. |
Sustained-release pharaceutical preparation
|
SE8601624D0
(sv)
|
1986-04-11 |
1986-04-11 |
Haessle Ab |
New pharmaceutical preparations
|
IT1200217B
(it)
|
1986-09-30 |
1989-01-05 |
Valducci Roberto |
Membrana per uso farmaceutico ed industriale
|
SE8605515D0
(sv)
|
1986-12-22 |
1986-12-22 |
Astra Laekemedel Ab |
A liquid dosage form for oral administration of a pharmaceutically active substance
|
US5026560A
(en)
|
1987-01-29 |
1991-06-25 |
Takeda Chemical Industries, Ltd. |
Spherical granules having core and their production
|
JPH0832625B2
(ja)
*
|
1987-01-29 |
1996-03-29 |
武田薬品工業株式会社 |
有核顆粒およびその製造法
|
DE3887179T2
(de)
|
1987-03-02 |
1994-06-16 |
Brocades Pharma Bv |
Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
|
GB8705083D0
(en)
|
1987-03-04 |
1987-04-08 |
Euro Celtique Sa |
Spheroids
|
US4902513A
(en)
*
|
1987-07-31 |
1990-02-20 |
Jean Carvais |
Oral sustained release medicament
|
DE3810757A1
(de)
|
1988-03-30 |
1989-10-26 |
Freudenberg Carl Fa |
Verfahren zur herstellung einer mikroporoesen folie
|
US5268182A
(en)
|
1988-06-24 |
1993-12-07 |
Abbott Laboratories |
Sustained-release drug dosage units of terazosin
|
FR2634377B1
(fr)
|
1988-06-30 |
1991-09-27 |
Cortial |
Nouvelle forme pharmaceutique a liberation prolongee a base d'un complexe resine-principe actif
|
US5028434A
(en)
*
|
1988-07-21 |
1991-07-02 |
Alza Corporation |
Method for administering nilvadipine for treating cardiovascular symptoms
|
US5186930A
(en)
*
|
1988-11-14 |
1993-02-16 |
Schering Corporation |
Sustained release oral suspensions
|
US4999189A
(en)
*
|
1988-11-14 |
1991-03-12 |
Schering Corporation |
Sustained release oral suspensions
|
IT1227899B
(it)
|
1988-12-23 |
1991-05-14 |
Poli Ind Chimica Spa |
Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
|
FR2642080B1
(fr)
*
|
1989-01-23 |
1992-10-02 |
Onera (Off Nat Aerospatiale) |
Polysilanes et leur procede de preparation
|
US4948581A
(en)
|
1989-02-17 |
1990-08-14 |
Dojin Iyaku-Kako Co., Ltd. |
Long acting diclofenac sodium preparation
|
US5026559A
(en)
|
1989-04-03 |
1991-06-25 |
Kinaform Technology, Inc. |
Sustained-release pharmaceutical preparation
|
US5133974A
(en)
*
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
US5084278A
(en)
*
|
1989-06-02 |
1992-01-28 |
Nortec Development Associates, Inc. |
Taste-masked pharmaceutical compositions
|
AU632602B2
(en)
|
1989-08-02 |
1993-01-07 |
John David Arnold |
Method and preparation for reducing risk of myocardial infarction
|
NZ233975A
(en)
|
1989-08-16 |
1992-06-25 |
Sterling Drug Inc |
Aspirin granules coated with a gastroprotectant
|
IT1256651B
(it)
|
1992-12-11 |
1995-12-12 |
Giancarlo Santus |
Composizione farmaceutica a rilascio controllato in sospensione liquida
|
US5248516A
(en)
*
|
1989-12-19 |
1993-09-28 |
Fmc Corporation |
Film-forming composition: method of producing same and use for coating pharmaceuticals and foods and the like
|
GB9002495D0
(en)
|
1990-02-05 |
1990-04-04 |
Monsanto Europe Sa |
Glyphosate compositions
|
US5206030A
(en)
*
|
1990-02-26 |
1993-04-27 |
Fmc Corporation |
Film-forming composition and use for coating pharmaceuticals, foods and the like
|
IT1246383B
(it)
*
|
1990-04-17 |
1994-11-18 |
Eurand Int |
Metodo per il mascheramento del sapore di farmaci
|
CA2085342A1
(en)
|
1990-06-14 |
1991-12-15 |
Milton R. Kaplan |
Stable aqueous drug suspensions
|
SE9002684D0
(sv)
*
|
1990-08-17 |
1990-08-17 |
Malvac Foundation C O Peter Pe |
New peptides and their use
|
US5219895A
(en)
*
|
1991-01-29 |
1993-06-15 |
Autogenesis Technologies, Inc. |
Collagen-based adhesives and sealants and methods of preparation and use thereof
|
US5431922A
(en)
*
|
1991-03-05 |
1995-07-11 |
Bristol-Myers Squibb Company |
Method for administration of buspirone
|
FI922107A0
(fi)
|
1991-05-10 |
1992-05-08 |
Faulding F H & Co Ltd |
Mikrokapselkomposition och foerfarande.
|
US5286497A
(en)
*
|
1991-05-20 |
1994-02-15 |
Carderm Capital L.P. |
Diltiazem formulation
|
IT1250421B
(it)
|
1991-05-30 |
1995-04-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
|
US5464632C1
(en)
|
1991-07-22 |
2001-02-20 |
Prographarm Lab |
Rapidly disintegratable multiparticular tablet
|
ATE154241T1
(de)
*
|
1991-10-01 |
1997-06-15 |
Takeda Chemical Industries Ltd |
Mikropartikeln-zusammenfassung zur verlängerten freigabe und herstellung derselbe
|
US5656295A
(en)
*
|
1991-11-27 |
1997-08-12 |
Euro-Celtique, S.A. |
Controlled release oxycodone compositions
|
US5409709A
(en)
*
|
1991-11-29 |
1995-04-25 |
Lion Corporation |
Antipyretic analgesic preparation containing ibuprofen
|
US5571533A
(en)
|
1992-02-07 |
1996-11-05 |
Recordati, S.A., Chemical And Pharmaceutical Company |
Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
|
US5286495A
(en)
*
|
1992-05-11 |
1994-02-15 |
University Of Florida |
Process for microencapsulating cells
|
KR940003548U
(ko)
*
|
1992-08-14 |
1994-02-21 |
김형술 |
세탁물 건조기
|
IL103224A
(en)
*
|
1992-09-18 |
1998-08-16 |
Teva Pharma |
Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
|
US5594016A
(en)
*
|
1992-12-28 |
1997-01-14 |
Mitsubishi Chemical Corporation |
Naphthalene derivatives
|
FR2704146B1
(fr)
|
1993-04-19 |
1995-07-13 |
Cripdom |
Microcapsules d'acide acétylsalicylique à libération contrôlée.
|
FR2708932B1
(fr)
*
|
1993-08-10 |
1995-11-10 |
Flamel Tech Sa |
Procédé de préparation de polyaminoacides.
|
EP1442745A1
(en)
|
1993-10-07 |
2004-08-04 |
Euro-Celtique |
Orally administrable opioid formulations having extended duration of effect
|
GB9401894D0
(en)
|
1994-02-01 |
1994-03-30 |
Rhone Poulenc Rorer Ltd |
New compositions of matter
|
JP2977907B2
(ja)
*
|
1994-05-06 |
1999-11-15 |
ファイザー・インコーポレーテッド |
アジスロマイシンの放出調節された剤形
|
IT1270594B
(it)
*
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
FR2725623A1
(fr)
*
|
1994-10-18 |
1996-04-19 |
Flamel Tech Sa |
Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
|
US5858398A
(en)
*
|
1994-11-03 |
1999-01-12 |
Isomed Inc. |
Microparticular pharmaceutical compositions
|
KR0167613B1
(ko)
|
1994-12-28 |
1999-01-15 |
한스 루돌프 하우스, 니콜 케르커 |
사이클로스포린-함유 연질캅셀제 조성물
|
US5834024A
(en)
*
|
1995-01-05 |
1998-11-10 |
Fh Faulding & Co. Limited |
Controlled absorption diltiazem pharmaceutical formulation
|
JP2690276B2
(ja)
|
1995-01-10 |
1997-12-10 |
科学技術振興事業団 |
静電結合型高分子ミセル薬物担体とその薬剤
|
FR2732218B1
(fr)
|
1995-03-28 |
1997-08-01 |
Flamel Tech Sa |
Particules a base de polyaminoacide(s) et susceptibles d'etre utilisees comme vecteurs de principe(s) actif(s) et leurs procedes de preparation
|
US5750468A
(en)
*
|
1995-04-10 |
1998-05-12 |
Monsanto Company |
Glyphosate formulations containing etheramine surfactants
|
US5674529A
(en)
|
1995-06-06 |
1997-10-07 |
Church & Dwight Co., Inc. |
Alkalinizing potassium salt controlled release preparations
|
US5945124A
(en)
*
|
1995-07-05 |
1999-08-31 |
Byk Gulden Chemische Fabrik Gmbh |
Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
|
JPH11510811A
(ja)
*
|
1995-08-12 |
1999-09-21 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
医薬処方
|
IT1276130B1
(it)
*
|
1995-11-14 |
1997-10-27 |
Gentili Ist Spa |
Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
|
US6245351B1
(en)
|
1996-03-07 |
2001-06-12 |
Takeda Chemical Industries, Ltd. |
Controlled-release composition
|
FR2746035B1
(fr)
*
|
1996-03-15 |
1998-06-12 |
|
Microparticules de gel composite susceptibles d'etre utilisees comme vecteur(s) de principe(s) actif(s), l'un de leurs procedes de preparation et leurs applications
|
US20030064108A1
(en)
*
|
1996-04-23 |
2003-04-03 |
Stefan Lukas |
Taste masked pharmaceutical compositions
|
FR2752732B1
(fr)
*
|
1996-08-28 |
1998-11-20 |
Pf Medicament |
Forme galenique a liberation prolongee de milnacipran
|
US5780055A
(en)
*
|
1996-09-06 |
1998-07-14 |
University Of Maryland, Baltimore |
Cushioning beads and tablet comprising the same capable of forming a suspension
|
GB2318511A
(en)
*
|
1996-10-23 |
1998-04-29 |
Eurand Int |
Process for the preparation of a pharmaceutical composition for rapid suspension in water
|
CA2275475A1
(en)
|
1996-12-19 |
1998-06-25 |
Hiroshi Kikuchi |
Pharmaceutical composition for oral administration
|
FR2759083B1
(fr)
|
1997-02-06 |
1999-04-30 |
Dev Des Utilisations Du Collag |
Materiau collagenique utile notamment pour la prevention d'adherences post-operatoires
|
JP3136516B2
(ja)
*
|
1997-03-25 |
2001-02-19 |
武田薬品工業株式会社 |
消化管粘膜付着性抗ヘリコバクター・ピロリ組成物
|
US5981761A
(en)
|
1997-03-27 |
1999-11-09 |
Solutia Inc. |
Crosslinked polyaspartate salts a process for their production
|
US6162463A
(en)
|
1997-05-01 |
2000-12-19 |
Dov Pharmaceutical Inc |
Extended release formulation of diltiazem hydrochloride
|
DE69828635T2
(de)
*
|
1997-09-19 |
2005-06-16 |
Shire Laboratories, Inc. |
Feste lösungskügelchen
|
US6472373B1
(en)
|
1997-09-21 |
2002-10-29 |
Schering Corporation |
Combination therapy for eradicating detectable HCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection
|
FR2771291B1
(fr)
*
|
1997-11-21 |
2000-02-25 |
Ethypharm Lab Prod Ethiques |
Spheroides, procede de preparation et compositions pharmaceutiques
|
CN1204890C
(zh)
*
|
1997-12-22 |
2005-06-08 |
欧罗赛铁克股份有限公司 |
防止阿片样物质滥用的方法
|
EA003101B1
(ru)
|
1998-03-19 |
2002-12-26 |
Бристол-Майерз Сквибб Компани |
Двухфазная система доставки с регулируемым высвобождением для фармацевтических средств с высокой растворимостью и способ лечения диабета с помощью этой системы
|
CN1293576A
(zh)
|
1998-03-20 |
2001-05-02 |
兴和株式会社 |
胃和/或十二指肠粘附性药物组合物
|
JPH11269064A
(ja)
*
|
1998-03-20 |
1999-10-05 |
Kowa Co |
胃・十二指腸付着性医薬組成物
|
JPH11322588A
(ja)
*
|
1998-03-20 |
1999-11-24 |
Kowa Co |
胃・十二指腸付着性医薬組成物
|
US6184220B1
(en)
*
|
1998-03-27 |
2001-02-06 |
Boehringer Ingelheim Pharma Kg |
Oral suspension of pharmaceutical substance
|
US5945123A
(en)
*
|
1998-04-02 |
1999-08-31 |
K-V Pharmaceutical Company |
Maximizing effectiveness of substances used to improve health and well being
|
ATE250418T1
(de)
|
1998-07-15 |
2003-10-15 |
Merck Sante Sas |
Tabletten enthaltend eine kombination von glibenclamid und metformin
|
KR100501022B1
(ko)
|
1998-07-28 |
2005-07-18 |
다나베 세이야꾸 가부시키가이샤 |
장내 적소 방출형 제제
|
US6319513B1
(en)
*
|
1998-08-24 |
2001-11-20 |
The Procter & Gamble Company |
Oral liquid mucoadhesive compounds
|
US6099862A
(en)
*
|
1998-08-31 |
2000-08-08 |
Andrx Corporation |
Oral dosage form for the controlled release of a biguanide and sulfonylurea
|
US6303607B1
(en)
*
|
1998-09-10 |
2001-10-16 |
Cv Therapeutics, Inc. |
Method for administering a sustained release ranolanolazine formulation
|
JP2000128774A
(ja)
*
|
1998-10-26 |
2000-05-09 |
Tanabe Seiyaku Co Ltd |
薬物を含有する球形微粒子の製法
|
WO2000025752A1
(en)
*
|
1998-11-02 |
2000-05-11 |
Church, Marla, J. |
Multiparticulate modified release composition
|
FR2786098B1
(fr)
|
1998-11-20 |
2003-05-30 |
Flamel Tech Sa |
Particules a base de polyaminoacide(s) et susceptibles d'etre utilisees comme vecteurs de principe(s) actif(s), suspension colloidale les comprenant et leurs procedes de fabrication
|
US6419960B1
(en)
*
|
1998-12-17 |
2002-07-16 |
Euro-Celtique S.A. |
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
|
US7374779B2
(en)
*
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
JP2000256182A
(ja)
|
1999-03-03 |
2000-09-19 |
Kazuhiro Morimoto |
抗菌製剤
|
US7576131B2
(en)
|
1999-06-04 |
2009-08-18 |
Metabolex, Inc. |
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
US20030118641A1
(en)
*
|
2000-07-27 |
2003-06-26 |
Roxane Laboratories, Inc. |
Abuse-resistant sustained-release opioid formulation
|
BR0013825A
(pt)
*
|
1999-08-31 |
2002-07-23 |
Gruenenthal Chemie |
Formas de apresentação de tramadol
|
ES2168043B1
(es)
|
1999-09-13 |
2003-04-01 |
Esteve Labor Dr |
Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
|
US6264983B1
(en)
*
|
1999-09-16 |
2001-07-24 |
Rhodia, Inc. |
Directly compressible, ultra fine acetaminophen compositions and process for producing same
|
FR2801226B1
(fr)
|
1999-11-23 |
2002-01-25 |
Flamel Tech Sa |
Suspension colloidale de particules submicroniques de vectorisation de principes actifs et son mode de preparation
|
US6248359B1
(en)
*
|
2000-01-05 |
2001-06-19 |
Laboratorios Phoenix U.S.A., Inc. |
Multi-tablet oxybutynin system for treating incontinence
|
US7785625B2
(en)
*
|
2000-01-14 |
2010-08-31 |
Lg Life Sciences, Limited |
Lipophilic-coated microparticle containing a protein drug and formulation comprising same
|
JP2003522144A
(ja)
*
|
2000-02-08 |
2003-07-22 |
ユーロ−セルティーク,エス.エイ. |
オピオイドアゴニストおよびアンタゴニストを含む制御放出組成物
|
US6627223B2
(en)
|
2000-02-11 |
2003-09-30 |
Eurand Pharmaceuticals Ltd. |
Timed pulsatile drug delivery systems
|
US6534651B2
(en)
*
|
2000-04-06 |
2003-03-18 |
Inotek Pharmaceuticals Corp. |
7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof
|
US6815542B2
(en)
|
2000-06-16 |
2004-11-09 |
Ribapharm, Inc. |
Nucleoside compounds and uses thereof
|
FR2811571B1
(fr)
|
2000-07-11 |
2002-10-11 |
Flamel Tech Sa |
Composition pharmaceutique orale, permettant la liberation controlee et l'absorption prolongee d'un principe actif
|
IT1318625B1
(it)
*
|
2000-07-14 |
2003-08-27 |
Roberto Valducci |
Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente.
|
US6541014B2
(en)
*
|
2000-10-13 |
2003-04-01 |
Advancis Pharmaceutical Corp. |
Antiviral product, use and formulation thereof
|
US7074417B2
(en)
*
|
2000-10-13 |
2006-07-11 |
Advancis Pharmaceutical Corporation |
Multiple-delayed release anti-viral product, use and formulation thereof
|
US6499158B1
(en)
*
|
2000-10-30 |
2002-12-31 |
Steris, Inc. |
Surgical table top and accessory clamp used thereon
|
FR2816840B1
(fr)
|
2000-11-17 |
2004-04-09 |
Flamel Tech Sa |
Medicament a base de microcapsules d'anti-hyperclycemiant a liberation prolongee et son procede de preparation
|
BR0207932A
(pt)
*
|
2001-03-05 |
2004-03-02 |
Ortho Mcneil Pharm Inc |
Composições farmacêuticas de sabor mascarado
|
BR0102252B1
(pt)
|
2001-04-10 |
2013-10-22 |
|
Sistema de liberação controlada para antagonista do receptor AT1 da angiotensina II, composição farmacêutica e seu uso
|
US6946146B2
(en)
|
2001-04-18 |
2005-09-20 |
Nostrum Pharmaceuticals Inc. |
Coating for a sustained release pharmaceutical composition
|
US7842307B2
(en)
*
|
2001-08-06 |
2010-11-30 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
|
EP1429728A1
(en)
*
|
2001-08-29 |
2004-06-23 |
SRL Technologies, Inc. |
Sustained release preparations
|
US20030050620A1
(en)
*
|
2001-09-07 |
2003-03-13 |
Isa Odidi |
Combinatorial type controlled release drug delivery device
|
US20030059397A1
(en)
|
2001-09-17 |
2003-03-27 |
Lyn Hughes |
Dosage forms
|
FR2830447B1
(fr)
|
2001-10-09 |
2004-04-16 |
Flamel Tech Sa |
Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
US20030104052A1
(en)
*
|
2001-10-25 |
2003-06-05 |
Bret Berner |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
US20040126428A1
(en)
|
2001-11-02 |
2004-07-01 |
Lyn Hughes |
Pharmaceutical formulation including a resinate and an aversive agent
|
FR2837100B1
(fr)
|
2002-03-18 |
2004-07-23 |
Flamel Tech Sa |
Comprimes a bases de microcapsules a liberation modifiee
|
EP1490029A4
(en)
*
|
2002-03-22 |
2006-02-22 |
Ranbaxy Lab Ltd |
DRUG DELIVERY SYSTEM WITH CONTROLLED RELEASE OF PRAVASTATIN
|
US20050106249A1
(en)
*
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
CN1671358A
(zh)
|
2002-05-31 |
2005-09-21 |
阿尔扎公司 |
用于渗透传递可变剂量的羟考酮的剂型和组合物
|
FR2840614B1
(fr)
|
2002-06-07 |
2004-08-27 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
|
FR2842736B1
(fr)
*
|
2002-07-26 |
2005-07-22 |
Flamel Tech Sa |
Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
|
FR2843117B1
(fr)
|
2002-07-30 |
2004-10-15 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
|
US6727839B2
(en)
|
2002-08-23 |
2004-04-27 |
Broadcom Corporation |
High speed, low power comparator
|
US7538094B2
(en)
*
|
2002-09-19 |
2009-05-26 |
Three Rivers Pharmacueticals, Llc |
Composition containing ribavirin and use thereof
|
TWI332507B
(en)
*
|
2002-11-19 |
2010-11-01 |
Hoffmann La Roche |
Antiviral nucleoside derivatives
|
MXPA05005812A
(es)
*
|
2002-12-11 |
2005-08-16 |
Pfizer Prod Inc |
Liberacion controlada de una sustancia activa a un entorno rico en grasa.
|
JP2004188307A
(ja)
*
|
2002-12-11 |
2004-07-08 |
Japan Atom Energy Res Inst |
リン酸基を有するジルコニウム担持繊維状吸着材の合成方法、及びそれを用いたヒ素の除去
|
TWI347201B
(en)
|
2003-04-21 |
2011-08-21 |
Euro Celtique Sa |
Pharmaceutical products,uses thereof and methods for preparing the same
|
FR2862536B1
(fr)
*
|
2003-11-21 |
2007-11-23 |
Flamel Tech Sa |
Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
|
HUE037643T2
(hu)
|
2004-06-12 |
2018-09-28 |
Collegium Pharmaceutical Inc |
Visszaélésre nem alkalmas gyógyszerkészítmények
|
CA2581816A1
(en)
*
|
2004-09-27 |
2006-04-06 |
Sigmoid Biotechnologies Limited |
Microcapsules comprising a methylxanthine and a corticosteroid
|
US20070166378A1
(en)
*
|
2005-06-09 |
2007-07-19 |
Flamel Technologies, Inc. |
Oral ribavirin pharmaceutical compositions
|